Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03985215
Other study ID # 2016-051-000001
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date December 2020
Est. completion date November 2021

Study information

Verified date July 2020
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to evaluate the family perspective on follow-up programs after treatment for childhood acute lymphoblastic leukaemia. It is relevant when new follow-up programs are to be designed.


Description:

More than 90 % of paediatric patients with acute lymphoblastic leukaemia (ALL), treated on the Nordic Society of Pediatric Hematology and Oncology (NOPHO) ALL-2008 protocol, are alive five years after diagnosis. The main reason for treatment failure being relapse.

The risk of relapse after treatment for ALL is highest within the first two years after cessation of maintenance therapy. Therefore, it has been routine in most countries to follow-up patients in the outpatient clinic every one or two months during the first years after end of therapy for ALL in order to detect recurrence and possible late sequelae at an early stage.

In children with ALL there are only a few studies on the value of routine follow-up, including haematological status after cessation of maintenance therapy. These studies showed that approximately 90% of the relapses were diagnosed in children with symptoms of leukaemia progression and that routine blood tests and clinical follow-ups were of little value. It is well known that there are other issues besides the risk of relapse, which are relevant for families after cessation of ALL therapy i.e. risk of late effects of treatment, psychosocial problems related to the child's return to "normal" life etc. These issues will also have an impact upon how the follow-up programs are planned. The investigators will study the family perspectives on follow-up during the first 5-years after cessation of maintenance therapy in a Danish cohort of children treated according to the NOPHO ALL-2008 protocol.

The investigators will conduct a cross-sectional study. Outcomes are patient-reported as the measurement instrument used is questionnaires. Eligible families are families with children diagnosed with acute lymphoblastic leukaemia in Denmark and being in the period 0-5 years after cessation of maintenance therapy.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date November 2021
Est. primary completion date July 2021
Accepts healthy volunteers No
Gender All
Age group 1 Year to 15 Years
Eligibility Inclusion Criteria:

- Patients with B-precursor ALL and T-ALL enrolled in the NOPHO ALL-2008 trial

- Age group 1.0-14.9 years.

- Patients treated on one of the four Danish Paediatric oncology departments

- Patients in the time period 0-5 years after cessation of maintenance therapy for ALL

Exclusion Criteria:

- A history of recurrence or second malignancies

- Bone marrow transplantation

- Down syndrome

- If, due to language barriers, the family is unable to complete the questionnaire.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaires
Pediatric Quality of Life Inventory questionnaire. Self-designed questionnaire.

Locations

Country Name City State
Denmark Karen Schow Jensen Aarhus Aarhus N

Sponsors (1)

Lead Sponsor Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Degree of parental concern Self-designed questionnaire. Six items scored on a scale 1-7. Higher values represent a worse outcome. An average is calculated over the six items.
An item evaluating the need for extra visits on a scale 1-3. Higher values represent a worse outcome.
An item evaluating parental reported worries about the future on a scale 1-5. Higher values represent a worse outcome.
A single point in time when questionnaires are answered. The specific time point being 0-5 years after end of ALL treatment.
Secondary Satisfaction with the follow-up program Self-designed questionnaire. An item evaluating satisfaction the time interval between visits on a scale 1-3. Higher values represent a worse outcome. A single point in time when questionnaires are answered. The specific time point being 0-5 years after end of ALL treatment.
Secondary PedsQL scores Pediatric Quality of Life Inventory questionnaire (the parent proxy). A validated measure of health-related quality of life. A single point in time when questionnaires are answered. The specific time point being 0-5 years after end of ALL treatment.
Secondary The amount of self-reported side effects Self-designed questionnaire. Fifteen items scored on a scale 1-7. Higher values represent a worse outcome. An average is calculated over the fifteen items.
An item evaluating the duration of the time period before the child was able to attend day-care/school on a scale 1-5. Higher values represent a worse outcome.
A single point in time when questionnaires are answered. The specific time point being 0-5 years after end of ALL treatment.
Secondary Strategy of the families between follow-up visits Self-designed questionnaire. In need of advice between visits what are the strategy of the participants: seeking hospital, general practitioner or postponing till next scheduled visit. A single point in time when questionnaires are answered. The specific time point being 0-5 years after end of ALL treatment.
See also
  Status Clinical Trial Phase
Recruiting NCT04105491 - Patient's Expectations, Preferences, Experiences Before, During and After the Treatment With Invisalign® Aligners
Completed NCT03685227 - A Closer Look at Yoga Nidra: Sleep Lab Analyses N/A
Recruiting NCT06397495 - Comparison of Learning Models in Physical Therapy Education N/A
Completed NCT04169646 - Prevention and Intervention of Neck Pain in Swiss Office-Workers N/A
Completed NCT04506918 - Comparison of SMS and IVR Surveys in Tanzania N/A
Recruiting NCT06410014 - Assessment of Overall Functioning in Patients With Complex Health Issues
Completed NCT04832711 - A Community Study of the Risk for Obstructive Sleep Apnea and Respiratory Inflammation in an Adult Chinese Population
Active, not recruiting NCT03805490 - Translation, Cross Cultural Adaptation and Validation of the Italian Version of the Forgotten Joint Score in Total Knee Arthroplasty
Recruiting NCT03335644 - The NutriNet-Santé Study
Completed NCT03768323 - Airtime Incentive Amounts to Improve Interactive Voice Response Surveys in Bangladesh and Uganda N/A
Completed NCT03773146 - Use of Airtime Structure to Improve Interactive Voice Response Surveys in Bangladesh and Uganda N/A
Completed NCT03772431 - Use of Narrative Voice and Introduction Content to Improve Interactive Voice Response Surveys in Bangladesh and Uganda N/A
Completed NCT04513236 - Use of Airtime Timing to Improve Interactive Voice Response Surveys in Bangladesh and Uganda N/A
Completed NCT02865525 - Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring.
Terminated NCT02708303 - Mayo Clinic Foregut Surgery Report Card Questionnaire
Completed NCT03772509 - Use of Introduction Mode to Improve Interactive Voice Response Surveys in Bangladesh and Tanzania N/A
Completed NCT03162835 - Development and Clinimetric Properties of the Dutch Pediatric Neurophysiology of Pain Questionnaire in Healthy Children
Completed NCT04684316 - Economic Evaluation of Periodic Occupational Health Screening N/A
Completed NCT04417556 - Validation of Various Sleep Assessment Tools in SICU N/A
Completed NCT04506931 - Comparison of SMS, IVR, and CATI Surveys in Colombia N/A